Company Filing History:
1 out of 191 
1 out of 1,001 
1 out of 328 
Years Active: 1993
Title: Masakatsu Wada: Innovator in Hybrid Plasminogen Activator Technologies
Introduction: Masakatsu Wada is a notable inventor based in Sagamihara, Japan, recognized for his innovative contributions to biochemistry and molecular biology. He holds one patent that showcases his expertise in developing hybrid polypeptides aimed at advancing medical technologies.
Latest Patents: Wada's patent, titled "Hybrid tissue plasminogen activator/urokinase polypeptides," focuses on a hybrid plasminogen activator-like polypeptide. This invention comprises a polypeptide region responsible for an affinity to fibrin derived from a tissue plasminogen activator polypeptide, alongside a polypeptide region responsible for enzyme activity derived from a prourokinase polypeptide. The patent also includes a DNA segment coding for the hybrid polypeptide, a plasmid containing the DNA segment, and a microorganism transformed with the DNA. Moreover, Wada details a process for producing the hybrid polypeptide, which involves culturing the microorganism and recovering the hybrid polypeptide from the cultured cells.
Career Highlights: Throughout his career, Masakatsu Wada has significantly impacted the field of chemical research, having contributed his skills and knowledge at the Sagami Chemical Research Center and Central Glass Company, Limited. His work in these prestigious organizations showcases his dedication to scientific progress and innovation.
Collaborations: Wada has collaborated with notable colleagues, including Michito Tagawa and Masayuki Yamada, to further explore the potential of hybrid polypeptides in medical applications. These collaborations have been crucial in enhancing the research and development of his patented technologies.
Conclusion: Masakatsu Wada stands out as an inventor who has made significant strides in the realm of hybrid plasminogen activator technologies. His patent reflects his commitment to advancing biochemistry and contributing to medical science, paving the way for future innovations in the field.